<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30357537</PMID>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>25</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1932-2267</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                        <Day>24</Day>                    </PubDate>                </JournalIssue>                <Title>Journal of cancer survivorship : research and practice</Title>                <ISOAbbreviation>J Cancer Surviv</ISOAbbreviation>            </Journal>            <ArticleTitle>Financial toxicity is more than costs of care: the relationship between employment and financial toxicity in long-term cancer survivors.</ArticleTitle>            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11764-018-0723-7</ELocationID>            <Abstract>                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The aim of this study was to examine the relationship between employment and financial toxicity by examining the prevalence of, and factors associated with, financial toxicity among cancer survivors.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a secondary analysis of a sub-sample from the Dutch Patient Reported Outcomes Following Initial Treatment and Long-term Evaluation of Survivorship (PROFILES) registry. Descriptive statistics, bivariate analysis and logistic regression were used.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 2931 participants with diverse cancer types were included in the analysis with a mean age of 55 years (range 18 to 65). Nearly half (49%) of participants were employed at the time of the survey, and 22% reported financial toxicity. Those who were not employed were at greater risk of financial toxicity (27% vs 16%, p &lt; 0.001), and this did not vary according to time since diagnosis. The odds of reporting financial toxicity were greater for participants who were male, younger, unmarried, with low education, low socioeconomic status, or without paid employment. Those with basal cell carcinoma had lower risk of financial toxicity, while those with haematological or colorectal cancer had highest risk of financial toxicity.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This research confirms that unemployment is significantly associated with financial toxicity and that those with limited financial resources are most at risk.</AbstractText>                <AbstractText Label="IMPLICATIONS FOR CANCER SURVIVORS" NlmCategory="CONCLUSIONS">Increased awareness of financial toxicity and its associated factors among clinicians may result in improved screening and appropriate referrals for support services. The implementation of effective multidisciplinary return to work interventions, as part of standard cancer survivorship care, may reduce financial toxicity among cancer survivors.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Pearce</LastName>                    <ForeName>Alison</ForeName>                    <Initials>A</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-5690-9542</Identifier>                    <AffiliationInfo>                        <Affiliation>Centre for Health Economics Research and Evaluation, University of Technology Sydney, PO Box 123, Broadway, NSW, 2007, Australia. Alison.pearce@chere.uts.edu.au.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tomalin</LastName>                    <ForeName>Bianca</ForeName>                    <Initials>B</Initials>                    <AffiliationInfo>                        <Affiliation>Flinders Centre for Innovation in Cancer, Flinders University, Adelaide, Australia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kaambwa</LastName>                    <ForeName>Billingsley</ForeName>                    <Initials>B</Initials>                    <AffiliationInfo>                        <Affiliation>Health Economics Unit, Flinders University, Adelaide, Australia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Horevoorts</LastName>                    <ForeName>Nicole</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Research, The Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Duijts</LastName>                    <ForeName>Saskia</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Public and Occupational Health, Amsterdam Public Health Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of General Practice, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mols</LastName>                    <ForeName>Floortje</ForeName>                    <Initials>F</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Research, The Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>van de Poll-Franse</LastName>                    <ForeName>Lonneke</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Research, The Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Koczwara</LastName>                    <ForeName>Bogda</ForeName>                    <Initials>B</Initials>                    <AffiliationInfo>                        <Affiliation>Flinders Centre for Innovation in Cancer, Flinders University, Adelaide, Australia.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>Chancellor's Postdoctoral Research Fellowship</GrantID>                    <Agency>University of Technology Sydney</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>VUP 2013-5866</GrantID>                    <Agency>KWF Kankerbestrijding</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>Fellowship</GrantID>                    <Agency>National Breast Cancer Foundation</Agency>                    <Country/>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>24</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>J Cancer Surviv</MedlineTA>            <NlmUniqueID>101307557</NlmUniqueID>            <ISSNLinking>1932-2259</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Cancer</Keyword>            <Keyword MajorTopicYN="N">Cost</Keyword>            <Keyword MajorTopicYN="N">Employment</Keyword>            <Keyword MajorTopicYN="N">Financial toxicity</Keyword>            <Keyword MajorTopicYN="N">Survivorship</Keyword>            <Keyword MajorTopicYN="N">Work</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>04</Month>                <Day>26</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>10</Month>                <Day>11</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>26</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>26</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>26</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30357537</ArticleId>            <ArticleId IdType="doi">10.1007/s11764-018-0723-7</ArticleId>            <ArticleId IdType="pii">10.1007/s11764-018-0723-7</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>